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The transcription factor NR4A1 is 
essential for the development of 
a novel macrophage subset in the 
thymus
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Tissue macrophages function to maintain homeostasis and regulate immune responses. While 
tissue macrophages derive from one of a small number of progenitor programs, the transcriptional 
requirements for site-specific macrophage subset development are more complex. We have 
identified a new tissue macrophage subset in the thymus and have discovered that its development 
is dependent on transcription factor NR4A1. Functionally, we find that NR4A1-dependent 
macrophages are critically important for clearance of apoptotic thymocytes. These macrophages 
are largely reduced or absent in mice lacking NR4A1, and Nr4a1-deficient mice have impaired 
thymocyte engulfment and clearance. Thus, NR4A1 functions as a master transcription factor for the 
development of this novel thymus-specific macrophage subset.
Macrophages are a heterogeneous population of phagocytic cells that are present in all tissues throughout 
the body1. At steady state, macrophages function in the maintenance of tissue homeostasis through the 
release of cytokines and growth factors, and through engulfment of apoptotic cells2. In times of stress (be 
it physical trauma or infection), macrophages clear invading pathogens and cellular debris, recruit and 
activate surrounding immune cells, and mediate wound repair3. Importantly, tissue-specific macrophages 
have also developed site-specific functions in order to best support the tissue that they inhabit4. Examples 
of this phenomenon are observed in the spleen where tissue-resident red pulp macrophages function to 
engulf aging red blood cells and recycle heme-associated iron1, and also in the bone where macrophages 
known as osteoclasts function as bone resorbing cells to maintain skeletal health5,6. Tissue-specific mac-
rophages not only vary in function, but also have different transcriptional requirements. For example, 
Spic is required for the development of splenic red pulp macrophages but is dispensable for the devel-
opment of other tissue macrophages7. Likewise, Gata6 expression is essential for tissue-specific develop-
ment and function of peritoneal macrophages4,8.
We have previously reported that the transcription factor NR4A1 controls the development of the 
non-classical, patrolling Ly6C− subset of monocytes. However, a role for NR4A1 in tissue macrophage 
development has not been determined. In this study, we assessed the capacity of NR4A1 to regulate 
tissue-resident macrophage development by examining macrophage frequencies in a variety of tissues 
in Nr4a1-deficient mice. We discovered a requirement for Nr4a1 in the development of a novel subset 
of macrophages present in the thymus. While macrophage populations present in the thymus have not 
been thoroughly characterized, it has long been appreciated that thymic macrophages are critical to 
the engulfment of apoptotic thymocytes; cells that are constantly being generated during both positive 
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and negative selection in lymphocyte development9. In this report we show that the population of 
NR4A1-dependent thymic macrophages actively engulfs apoptotic thymocytes. Further, we show that 
this NR4A1-dependent subset of thymic macrophages likely derives from bone marrow-progenitors, but 
does not depend on short-lived circulating monocytes for cell renewal.
Methods
Mice. C57BL/6J wild-type mice (000664), Nr4a1−/− (006187), Ccr2rfp/rfp (017586), Cx3cr1gfp/gfp 
(005582), Csf1reGFP (018549), Csf1op (000231), and B6.SJL-Ptprca Pepcb/BoyJ mice (002014) were obtained 
from The Jackson Laboratory. CD45.1.2 mice were generated by crossing C57BL/6J (CD45.2) mice to 
B6.SJL-PtprcaPepcb/BoyJ (CD45.1) mice. Generation of Flt3cre/wt;Rosa26LSL-eYFP/wt mice has been described 
previously10. Nr4a1flox mice were a gift from Professor Pierre Chambon, Institut de Genetique et de 
Biologie Moleculaire et Cellulaire, Illkirch-Graffenstaden, France. Nr4a1fl/fl mice were crossed to Csf1rcre/
wt (Jackson, 021024) mice and the resulting Nr4a1fl/fl;Csf1cre/wt mice were analyzed with Nr4a1wt/wt;Csf1cre/wt 
littermates used as controls. Nr4a1eGFP/cre (Jackson, 016617) mice were crossed to Rosa26tdTomato (Jackson, 
007905) mice and the resulting Nr4a1eGFP/cre+;Rosa26tdTomato+ mice were analyzed using cre-negative 
littermates as controls. All experiments followed guidelines of the La Jolla Institute for Allergy and 
Immunology Animal Care and Use Committee, and approval for the use of rodents was obtained from 
the La Jolla Institute for Allergy and Immunology according to criteria outlined in the Guide for the 
Care and Use of Laboratory Animals from the National Institutes of Health. Mice were euthanized by 
CO2 asphyxiation and cervical dislocation.
Tissue Processing. Blood was drawn from mice via cardiac puncture with an EDTA-coated syringe. 
Thymus and spleens were excised and pushed through a 70-μm strainer, and bone marrow cells from 
both femurs and tibias were collected by centrifugation. Brains were harvested from mice perfused 
with 10 mL Dulbecco’s PBS (Gibco), minced into small pieces, and digested in RPMI 1640 (Gibco) with 
300 μg/mL Liberase, and 100 U/mL DNase-I for 30 min at 37 °C. The tissue was then passed through a 
70-μm strainer and mononuclear cells were enriched by 30% Percoll-gradient centrifugation. All samples 
were collected in Dulbecco’s PBS (Gibco) and were stored on ice during staining and analysis. Red blood 
cells were lysed in RBC Lysis Buffer according to the manufacturer’s protocol (BioLegend).
Detection of anti-nuclear antibodies. Serum was collected from wild type and Nr4a1−/− animals 
following blood collection by cardiac puncture at the indicated times. Serum was isolated via centrifuga-
tion. To measure anti-nuclear antibodies, poly-L-lysine-coated EIA plates were first coated with genomic 
DNA. After the plates were blocked with 5% FBS in PBS, diluted mouse serum was added to each well 
and incubated at 4°C for 16 hrs. Horseradish peroxidase-conjugated anti-mouse IgG was used to detect 
DNA recognizing IgG. Peroxidase-mediated fluorescence was initiated using TMB substrate. Absorbance 
at 450 nm was measured by SpectraMax M5 (Molecular Device) ELISA reader. Data was analyzed by 
Softmax Pro3.6 software.
Flow Cytometry. 5 × 106 cells were resuspended in 100 μl staining buffer (1% BSA, 0.1% sodium azide 
in PBS). Cells were blocked with Fcγ receptor for 15 min and stained for surface antigens with flow 
cytometry Abs for 30 min at 4 °C. A fixable LIVE/DEAD stain (Invitrogen) was used to measure viability, 
and FSC/SSC parameters were used to exclude doublets from analysis. For intracellular staining, cells 
were treated using the Foxp3 Staining Kit (BD) according to the manufacture’s instructions. Cellular 
fluorescence was determined using a LSRII, or a FACSCalibur flow cytometer (BD Biosciences), and data 
analyses were performed with FlowJo software (Tree Star). The antibodies used in this study are shown 
in Supplementary Table 1.
Fluorescent Activated Cell Sorting (FACS). Prior to sorting, thymus cells were enriched for non-T 
cells via negative selection using the StemSeptm Anti-APC selection kit (StemCell Technologies) in con-
junction with APC-conjugated anti-CD90 (eBioscience) according to manufacturer’s instructions. Cells 
were then stained for surface antigens as described above and sorted using a FACSAria cell sorter (BD 
Biosciences). Approximately 5 × 104 events were collected, and used in qPCR, and in vitro experiments. 
An aliquot of thymic CD11b−F4/80+ cells were cytospun onto a microscope slide, stained with Hema3 
(Fisher Scientific), and analyzed by miscroscopy.
Quantitative Real-Time PCR (qRT-PCR). Total cellular RNA was collected from whole thymic 
tissue or from FACS isolated thymic macrophage populations using a Qiagen RNeasy Plus Micro Kit 
following the manufacturer’s protocol. RNA purity and quantity was measured using a nanodrop spec-
trophotometer (Thermo Scientific). Approximately 500 nanograms of RNA was used to synthesize cDNA 
using an iscript cDNA synthesis kit (Bio-Rad). Total cDNA was diluted 1:15 in H2O, and 9 μl were used 
for each real-time condition using a Bio-Rad MyIQ single-color real-time PCR detection system. Taqman 
primers and TaqMan Gene Expression Mastermix was used for the genes glyceraldehydes-3-phosphate 
dehydrogenase (GAPDH), Mertk, TYRO3, IL6, IL10, IL23a, and TNF (Supplementary Table 2). For the 
genes AXL, CD68, milk fat globule epidermal growth factor (EGF) factor 8 (MFGE8) and stabilin-2 
(STAB2), SYBR Green primers (Supplementary Table 3) and SYBR Green Gene Expression Mastermix 
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(Qiagen) were used. Data were analyzed and presented on the basis of the relative expression method. 
The formula for this calculation is as follows: relative expression = 2−(SΔ Ct − CΔC t) where Δ Ct is the differ-
ence in the threshold cycle between the gene of interest and the housekeeping gene (GAPDH), S are the 
CD11b−F4/80+ cells or Nr4A1−/− tissue, and C are the CD11b+F4/80+ cells or wild type tissue.
In vitro engulfment and phagocytosis assays. Sorted CD11b+F4/80+ and CD11b−F4/80+ mac-
rophages were incubated with apoptotic thymocytes for 1hr.. Uptake of labeled-thymocytes by the sorted 
macrophages was measured by flow cytometry. For the induction of apoptosis, thymocytes were incu-
bated with 50 μM Dexamethasone (Calbiochem Inc.) at 37 °C for 4 hours. The thymocytes were then 
washed and stained with pHrodo-succinimidyl ester (SE) (Molecular Probes), a pH-sensitive fluorescent 
dye used to assess engulfment due to the increase in the intensity of pHrodo light emission following 
the pH change once engulfed by a macrophage11. PHrodo-labeled thymocytes were then co-cultured 
with the sorted macrophages at a ratio of 10:1 (labeled thymocytes to sorted phagocytes). Forward and 
side-scatter parameters, as well as CD11b and F4/80 staining, were used to distinguish free unbound 
targets from phagocytes.
In vivo induction of thymocyte apoptosis. Wild type and Nr4a1-deficient mice were intraperito-
neally injected with 200 μl of PBS containing 250 μg dexamethasone dissolved in ethanol. 18 hours after 
injection, thymi were harvested and processed as described above, and stained for Annexin V and 7AAD 
using the PE Annexin V Apoptotis Kit I (BD Biosciences). Thymi were also embedded in OCT and then 
frozen on dry ice.
Histology. Embedded thymi were sectioned (10 μm) using a cryostat. The slides were subsequently 
fixed with 4% paraformaldehyde for 20 min. Sections stained for cleaved caspase-3 were permeablized in 
a 0.1% citrate, 0.1% Triton X solution for 10 min. The slides were then washed 3 times in PBS, blocked 
in 5% donkey serum with 0.1% Triton X in PBS for 60 min, and then incubated with a 1:500 dilution 
of rabbit anti-mouse cleaved caspase-3 (Asp175) antibody from Cell Signaling (#9661) or with a 1:50 
dilution of PE-conjugated anti-TIM4 (RMT4-54, eBioscience) diluted in PBS with 0.2% Triton X and 1% 
BSA overnight at 4 °C. The following day, Caspase-3 stained slides were then washed 3 times in PBS and 
incubated for 1 hour at room temperature with a donkey anti-rabbit Alexa488 fluorescently conjugated 
secondary antibody (Invitrogen). The slides were then stained with DAPI, washed 3 more times in PBS, 
and mounted with ProlongGold (Invitrogen). Images were acquired using an Olympus FV10i confocal 
microscope and analyzed using Imaris software (Bitplane).
Bone marrow transplantation studies. For bone marrow transplants, recipient mice (CD45.1) 
were irradiated in two doses of 550 rads each (for a total of 1,100 rads) 4 h apart. Bone marrow cells from 
both femurs and tibias of donor mice (wild-type CD45.2 or Nr4a1−/−) were collected under sterile condi-
tions. Approximately 5 × 106 nucleated bone marrow cells were obtained from each donor mouse. Bones 
were centrifuged for the collection of marrow, then cells were washed and resuspended in Dulbecco’s 
PBS for injection. Approximately 5 × 106 unfractionated bone marrow cells in 200 μl media were deliv-
ered retro-orbitally into each recipient mouse. Recipient mice were housed in a barrier facility under 
pathogen-free conditions before and after bone marrow transplantation. After bone marrow transplan-
tation, mice were provided autoclaved acidified water with antibiotics (trimethoprim-sulfamethoxazole) 
and were fed autoclaved food. Mice were used for experiments after 7 or 8 weeks of bone marrow recon-
stitution as indicated. In mixed bone marrow chimera studies 2.5 × 106 cells from Nr4a1−/− mice (CD45.2) 
and 2.5 × 106 cells from B6.CD45.1 mice were mixed at a ratio of 1:1 for reconstitution of recipients 
(wild-type, CD45.1) as described above.
Parabiosis. The procedure was performed as previously described12. Briefly, after shaving the corre-
sponding lateral aspects of each mouse, matching skin incisions were made from behind the ear to the 
tail of each mouse, and the subcutaneous fascia was bluntly dissected to create about 0.5 cm of free skin. 
The scapulas were sutured using a mono-nylon 5.0 (Ethicon, Albuquerque, NM), and the dorsal and 
ventral skins were approximated by continuous suture. Mice were joined for 4 weeks, and thymus and 
spleen were then collected and analyzed as described above.
Statistical analysis. Data for all experiments were analyzed using Prism software (GraphPad, San 
Diego, CA). Unpaired t tests were used to compare experimental groups. All experiments were repeated 
at least 3 times with 3 or more individuals per group. Data are graphically represented as mean ± SEM. 
A P value <0.05 was considered significant.
Results
Identification of a new subset of thymic macrophages and the dependence on NR4A1 for 
their development. To determine if NR4A1 functions in tissue macrophage development, we har-
vested brain, spleen, bone marrow, and thymus from Nr4a1−/− and wild type mice and examined each 
for the presence of tissue macrophages, identified as F4/80hi cells with varying levels of CD11b expres-
sion among the different tissues1,13,14. We found that the frequency of CD11b−F4/80+ cells in the thymus 
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was reduced in Nr4a1-deficient mice by over 60% (Fig. 1b, R2), whereas CD11b+F4/80+(R1) cells were 
unaltered. In the thymus, we utilized macrophage markers CD64 and Tim4 as additional means to assess 
the presence of thymus-resident macrophages, and found a similar reduction of CD11b−CD64+, and 
CD11b−Tim4+ cells in Nr4a1-deficient mice (Fig 1b,c). Tissue macrophage development in brain, spleen, 
and bone marrow was also unaffected indicating that Nr4a1-deficient mice do not display a global mac-
rophage deficiency (Fig. 2). Examination of other myeloid cell populations in thymus of Nr4a1-deficient 
mice revealed no changes in the frequency of neutrophils, eosinophils, cDCs (CD11b+CD11c+), or 
CD11b−CD11c+ DCs (Fig.  3). Given the substantial defect within the thymic CD11b−F4/80+ subset in 
Nr4a1−/− mice, we chose to focus our investigation on these cells.
While the presence of macrophages in the thymus has long been appreciated, thymic macrophage 
subsets have not been well characterized either phenotypically or functionally. We examined cell sur-
face molecules expressed by this thymic subset of CD11b−F4/80+ macrophages by flow cytometry, and 
found that they express CD45 and mononuclear phagocyte-associated (MPS; monocyte, macrophage, 
and dendritic cells) growth factor receptor CSF1R (Fig  4a). Furthermore, much like a wide array of 
MPS cells5, thymic CD11b−F4/80+ macrophages are also CSF-1 dependent as Csf-1-deficient mice (op/
Figure 1. Identification of a new NR4A1-dependent macrophage subset in the thymus. (a) Gating 
strategy for F4/80+ cells in the thymus. (b-d) Nr4a1+/+ and Nr4a1−/− cells from the thymus were stained 
with antibodies to CD11b, F4/80, CD64, and Tim4 and analyzed by flow cytometry. Frequency calculated 
as a percent of the total, live, singlet cells. Data are representative of at least three independent experiments 
(n = 14 mice). *** P < 0.001
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op) display defects in thymic CD11b−F4/80+ cell development (>60% reduction) that closely mirror that 
of Nr4a1-deficient mice (Supplemental Fig. 1). Thymic CD11b−F4/80+ cells also express the efferocytosis 
receptors Mertk and Tim4, as well as Fc IgG receptor CD64, and intermediate levels of MHCII (Fig. 4a). 
Dual expression of CD64 and Mertk is associated with mature tissue resident macrophages in spleen, 
brain, lung, and peritoneum14. Tissue resident macrophages in the peritoneum also express high levels of 
Tim415. Therefore, co-expression of Mertk, CD64, and Tim4 further supports the hypothesis that these 
CD11b−F4/80+ cells are part of the tissue resident macrophage population in the thymus. Importantly, 
thymic CD11b−F4/80+ cells also fail to express markers used to characterize a wide variety of leukocytes 
including inflammatory monocytes (Ly6C), DCs (CD11c), eosinophils (Siglec F), granulocytes (Ly6G), 
NK cells (Dx5), and B cells (B220) (Fig.  4b). Thymic CD11b−F4/80+ cells possess a macrophage-like 
morphology (Fig. 4c) that is also observed in situ via histological analysis of frozen thymic sections using 
confocal microscopy (Fig.  4d). Tim4 was used as a marker for thymic CD11b−F4/80+ cells during the 
histological analysis due to the exclusive expression within this population in the thymus (Supplemental 
Fig. 2).
Figure 2. Site specific regulation of tissue macrophages by NR4A1. Nr4a1+/+ and Nr4a1−/− cells from 
the indicated tissues were stained with antibodies to F4/80 and CD11b and analyzed by flow cytometry. 
Frequency calculated as a percent of the total, live, singlet cells in the corresponding tissue. Data are 
representative of at least three independent experiments (n = 9 mice).
www.nature.com/scientificreports/
6Scientific RepoRts | 5:10055 | DOi: 10.1038/srep10055
NR4A1-dependent thymic CD11b−F4/80+ cells are derived from bone marrow cells. Due to 
the requirement of NR4A1 for the development of thymic CD11b−F4/80+ macrophages, we assessed 
NR4A1 expression in these cells. This was accomplished by examining Nr4a1eGFP/cre × Rosa26tdTomato mice. 
These mice express tdTomato in any cell that has expressed NR4A1 during its development, and eGFP in 
cells currently expressing NR4A1. Surprisingly, we found that thymic CD11b−F4/80+ cells do not express 
eGFP, but highly express tdTomato (Fig. 5a). These data show that while thymic CD11b−F4/80+ cells do 
not constitutively express NR4A1, it is transiently expressed during their development.
To examine the developmental lineage of thymic CD11b−F4/80+ cells, we utilized a fate mapping 
strategy involving Flt3cre × RosaLSL−YFP mice. Growth factor receptor FLT3 is transiently expressed in 
pluripotent hematopoietic progenitors, and so any cell derived from the hematopoietic system in these 
mice will express yellow fluorescent protein (YFP)10. Analysis of Flt3cre × RosaLSL−YFP mice revealed that 
recombination was high in CD11b+F4/80+ thymic macrophages (>75%) as well as in NR4A1-dependent 
CD11b−F4/80+ thymic macrophages (>85%), indicating that these subsets are likely derived from bone 
marrow hematopoietic progenitors10 (Fig. 5b).
The observed defect in the development of thymic CD11b−F4/80+ cells in Nr4a1-deficient mice could 
result from either a cell-intrinsic defect, or from the loss of a required extrinsic factor produced by 
other cells in the thymus. To address this issue we first examined whether the Nr4a1-deficient bone 
marrow could effectively reconstitute CD11b−F4/80+ thymic macrophages by transplanting wild type or 
Nr4a1-deficient bone marrow into irradiated congenic wild-type recipients to assess the reconstitution 
of the macrophage compartments in the thymus after 7 weeks (Fig. 5c). We found that Nr4a1-deficient 
bone marrow failed to reconstitute the CD11b−F4/80+ subset in the thymus as we observed a defect in 
thymic CD11b−F4/80+ cell frequency (~40% reduction relative to control) that closely mirrors that of 
global Nr4a1-deficient mice.
Next, we performed mixed bone marrow chimera studies by transplanting a 1:1 mixture of bone 
marrow cells from wild type CD45.1.2 and Nr4a1-deficient CD45.2 donors into wild type CD45.1 recip-
ients (Fig. 5d). After reconstitution, we observed that cell numbers in the thymus were reconstituted in 
a 1:1 ratio of wild type to Nr4a1-deficient cells confirming that the donor bone marrow was injected 
at a 1:1 ratio. However, we found a 3:1 ratio of wild type to Nr4a1-deficient cells within the thymic 
CD11b−F4/80+ macrophage population, illustrating that Nr4a1-deficient bone marrow cells are signifi-
cantly outcompeted by wild type bone marrow cells in a cell-intrinsic fashion, and indicating that the 
development of this thymic macrophage population requires NR4A1. In contrast, the CD11b+F4/80+ 
Figure 3. Other myeloid cell populations in the thymus are unaffected in Nr4a1−/− mice. Thymus cells 
from Nr4a1+/+ and Nr4a1−/− mice were stained with antibodies to CD11b, CD11c, Siglec F, and Ly6G and 
analyzed by flow cytometry. (a) Dendritic cells were identified as CD11b+CD11c+ or CD11b−CD11c+ cells; 
(b) eosinophils as CD11b+Siglec F+ cells; (c) neutrophils as CD11b+Ly6G+ cells. Frequency calculated 
as a percent of the total, live, singlet cells in the thymus. Data are representative of three independent 
experiments (n = 9 mice).
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macrophage population was reconstituted equally (1:1) by wild type and Nr4a1-deficient marrow, indi-
cating that NR4A1 was critically and selectively important for the development of only the CD11b−F4/80+ 
macrophage population in thymus. These findings were corroborated by NR4A1 conditional knockout 
studies using Nr4a1flox × Csf1rcre mice where NR4A1 is only deleted in cells expressing CSF1R. Analysis 
of Nr4a1flox × Csf1rcre mice shows a significant reduction in CD11b−F4/80+ macrophages in the thymus 
(Fig. 5e).
At steady state, a large proportion of macrophages in a range of tissues including the brain and liver 
derive from HSC-independent yolk sac progenitors10. However, steady state macrophages from the lam-
ina propria derive from circulating CCR2+ monocytes16. To determine if thymic CD11b−F4/80+ cells are 
monocyte-derived, we analyzed blood monocyte and thymic macrophage populations in both Ccr2 and 
Cx3cr1-deficient animals and found the expected reductions of Ly6C+ and Ly6C− blood monocytes respec-
tively17,18 (Supplemental Fig. 3). However, no concomitant defects in thymic CD11b−F4/80+ macrophage 
Figure 4. Thymic CD11b−F4/80+ cells have a macrophage signature. (a,b) Thymus cells from C57BL/6 
mice were stained with the indicated antibodies and analyzed by flow cytometry. Plots were first gated on 
live CD11b−F4/80+ cells. Shaded histograms represent isotype controls. In the case of CSF1R expression, 
CsF1r-GFP+ mice were used, and the shaded histogram is derived from a Csf1r-GFP− mouse. (c) Hema3 
staining of thymic CD11b−F4/80+ cells sorted and cytospun from C57BL/6 mice. (d) Thymic sections from 
C57BL/6 mice were stained with DAPI (blue) to mark the nucleus and antibodies to Tim4 (red). Arrows 
indicate Tim4+ macrophages. All data representative of three independent experiments.
www.nature.com/scientificreports/
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development were observed in either mouse model (Fig.  5f), suggesting that these cells are likely not 
derived from adult circulating Ly6C+ or Ly6C− blood monocytes. These studies also further illustrate 
the critical dependence of these macrophages on NR4A1 for their development, as Nr4a1-deficient mice 
have a similar blood monocyte profile (greatly reduced Ly6C− monocyte numbers) to that of Cx3cr1−/− 
mice19,20. To further examine whether thymic CD11b−F4/80+ macrophages could be monocyte-derived, 
we assessed the chimerism of CD11b−F4/80+ thymic macrophages under parabiotic conditions. To do 
this, wild-type CD45.2 and CD45.1 mice were joined for four weeks, and chimerism of splenic mono-
cytes, splenic red pulp macrophages (RPMs), thymic CD11b+F4/80+, and thymic CD11b−F4/80+ mac-
rophages was determined. We found the expected 20-30% chimerism within the splenic monocyte pool 
in the parabionts, mirroring that of circulating monocytes12. We also found high chimerism among the 
thymic CD11b+F4/80+ population but very low chimerism among RPM (~0.5%), suggesting circulating 
Figure 5. NR4A1-dependent thymic CD11b−F4/80+ macrophages derive from the bone marrow. (a) 
Thymus cells from Nr4a1-eGFP/cre × Rosa26-tdTomato mice were gated on the CD11b−F4/80+ population 
and eGFP and tdTomato expression was assessed by flow cytometry. (b) Thymus cells from Rosa26-YFP+ 
mice were gated on the CD11b−F4/80+ population and YFP expression was assessed by flow cytometry. 
(c) Bone marrow cells from Nr4a1+/+(CD45.2) or Nr4a1−/−(CD45.2) mice were transferred into irradiated 
CD45.1 hosts. Reconstitution of thymic F4/80+ cells was assessed by flow cytometry after 7 weeks. Data are 
representative of at least three independent experiments (n = 9 mice). *** P < 0.001 (d) Csf1rcre−;Nr4a1flox/
flox and Csf1rcre+;Nr4a1flox/flox thymus cells were stained with antibodies to F4/80 and CD11b and analyzed 
by flow cytometry. (e) Bone marrow cells from Nr4a1+/+(CD45.1.2) and Nr4a1−/−(CD45.2) mice were 
transferred at a 1:1 ratio into irradiated CD45.1 hosts. Reconstitution of thymic CD11b−F4/80+ cells from 
each donor were assessed after 8 weeks. Data representative of four independent experiments (n = 22 mice). 
(f) Ccr2−/− and Cx3cr1−/− thymus cells were stained with antibodies to F4/80 and CD11b and analyzed by 
flow cytometry. Data representative of two independent experiments (n = 6). (g) Chimerism for spleen 
monocytes (mono), splenic red pulp macrophages (RPM), thymic CD11b+F4/80+, and thymic CD11b−F4/80+ 
cells in mice that had been joined in parabiosis for 4 weeks. (h) Ki67 expression in thymic CD11b+F4/80+ 
and CD11b−F4/80+ cells. Data representative of three independent experiments (n = 8 mice).
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monocyte dependence and independence, respectively. By comparison, the thymic CD11b−F4/80+ chi-
merism was very low (~2%), which argues against the concept that short lived, circulating, adult mono-
cytes replenish this population (Fig.  5g). Lastly, we examined whether thymic CD11b−F4/80+ cells 
could locally proliferate by staining with antibodies to nuclear proliferation antigen Ki67. We found 
Figure 6. NR4A1-dependent thymic CD11b−F4/80+ macrophages function as efficient efferocytes. (a) 
Expression of efferocytosis genes in sorted thymic CD11b+F4/80+ and CD11b− macrophages from C57BL/6 
mice. Expression was detected by real time qPCR and calculated relative to CD11b+F4/80+ cells. Data from 
three independent experiments. (b) Efferocytosis of pHrodo-labeled apoptotic thymocytes by sorted thymic 
CD11b+F4/80+ macrophages and CD11b−F4/80+ macrophages. Efferocytosis was detected by flow cytometry. 
Data representative of three independent experiments. * P < 0.05 (c) 7AAD and Annexin V staining from 
Nr4a1+/+ and Nr4a1−/− mice following 18 hr dexamethasone (dex) treatment. 8 animals per group. ** P < 0.01 
(d) Thymic sections from Nr4a1+/+ and Nr4a1−/− mice following 18hr dexamethasone treatment were stained 
with DAPI (blue) to mark the nucleus and antibodies to cleaved caspase-3 (green). Results representative of 
three mice per group.
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that over 6% of thymic CD11b−F4/80+ macrophages stained positively for Ki67 whereas substantially 
fewer (~0.8%) of circulation-derived CD11b+F4/80+ macrophages were Ki67-positive (Fig. 5h). Together 
these data show that while thymic CD11b−F4/80+ cells likely derive from the bone marrow, they are not 
derived from circulating short-lived monocytes at steady state. Further, this population of macrophages 
is proliferative, and thus is likely capable of self-renewal in thymic tissue.
NR4A1-dependent thymic CD11b–F4/80+ cells function as efferocytes to maintain thymic 
homeostasis. Due to high turnover of thymocytes during positive and negative selection for 
T-lymphocyte development, one of the major functions of macrophages in the thymus is to clear apop-
totic cells9. We therefore asked if this subset of CD11b−F4/80+ thymic macrophages was important in 
the efferocytosis of apoptotic cells in thymus. First, using qPCR, we found an enrichment of genes in 
wild-type CD11b− thymic macrophages that are functionally associated with the engulfment of apop-
totic cells (Fig.  6a). We found a several fold upregulation of a number of engulfment-associated genes 
including Mertk, Axl, Tyro3, and Mfg-e8 in thymic CD11b−F4/80+ macrophages relative to CD11b+F4/80+ 
thymic macrophages in wild-type mice. Thus this population of thymic macrophages likely functions in 
mice to regulate efferocytosis.
Next, to examine the capacity of each macrophage population to engulf apoptotic thymocytes in the 
process of efferocytosis, sorted thymic CD11b+F4/80+ and CD11b−F4/80+ macrophages were incubated 
with pHrodo-labeled apoptotic thymocytes. After 1 hour of incubation, the sorted macrophage popu-
lations were assessed for their ability to engulf the apoptotic thymocytes by flow cytometry (Fig.  6b). 
We found that roughly 55% of cultured CD11b−F4/80+ macrophages engulfed apoptotic thymocyte tar-
gets, while only roughly 8% of CD11b+F4/80+ macrophages did. Therefore, these results indicate that 
thymic CD11b−F4/80+ macrophages function as highly efficient efferocytes, and are likely the major 
Figure 7. Nr4a1−/− mice display accelerated thymic demise and increased auto antibody levels. (a) 
Cellularity of thymus from Nr4a1+/+ and Nr4a1−/− mice at 8wk and 36wk. 8 mice per group. * p < 0.05 (b) 
Inflammatory gene expression in the thymus of Nr4a1+/+ and Nr4a1−/− mice at 8wk and 36wk detected by 
real time qPCR. 6 mice per group. * P < 0.05. (c) Anti-DNA IgG (ANA) were measured from serum from 
mice aged from 4 to 18 weeks by ELISA. Anti-DNA antibody titer was significantly increased and peaked at 
18 weeks in Nr4a1−/−. ‘*’, and ‘**’ indicated P < 0.05 and P < 0.005, respectively.
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macrophage population in thymus that is responsible for clearing apoptotic thymocytes and maintaining 
thymic homeostasis.
Based upon these in vitro data, we wanted to see if Nr4a1-deficient mice were unable to efficiently 
clear apoptotic targets in the thymus in vivo. We injected wild type and Nr4a1-deficient mice with dex-
amethasone (Dex), a steroid that induces rapid apoptosis of thymocytes21. While wild-type animals 
showed only a modest increase in Annexin V+/7AAD+ cells 24 hr following Dex treatment, we observed 
a significant, two-fold accumulation of these late apoptotic/necrotic cells in Nr4a1−/− mouse thymus in 
vivo (Fig.  6c). Further, as a control, we examined whether NR4A1 deficiency altered thymocyte sensi-
tivity to Dex-induced apoptosis, and observed no difference in apoptotic cell induction between wild 
type and Nr4a1-deficient mice two hours following Dex injection (Supplemental Fig. 4). Apoptotic cell 
accumulation was also measured in thymus in situ following Dex injection of Nr4a1−/− and wild type 
mice by assessing cleaved caspase-3 expression (Fig.  6d). We found greater accumulation of apoptotic 
caspase-3+ thymocytes in Dex-injected Nr4a1−/− mice in thymus relative to wild type controls, again 
supporting the notion that this Nr4a1-dependent CD11b−F4/80+ macrophage subset plays an important 
role in clearance of apoptotic thymocytes during negative selection of lymphocytes in the thymus to aid 
in maintaining thymic homeostasis.
During the aging process the thymus begins to shrink in a process termed thymic involution22. As 
tissue macrophages are critical to maintenance of tissue homeostasis, we hypothesized that the loss of 
NR4A1-dependent thymic macrophages and the observed defective efferocytosis in these mice would 
alter homeostasis in the thymus and hasten thymic involution. To test this hypothesis, we examined 
thymic cellularity in both 8 week and 36 week-old wild type and Nr4a1-deficient mice, and found that 
while thymic cellularity was normal in Nr4a1-deficient mice at 8 weeks of age, at 36 weeks of age, the 
thymi of Nr4a1-deficient mice were significantly smaller (30% reduction in cellularity) than in wild type 
controls (Fig.  7a), indicating more rapid thymic demise in the Nr4a1−/− mice. Because expression of 
proinflammatory cytokines in the thymus is associated with involution23, we measured the expression of 
the cytokines Tnfa, Il6, Il23, and Il10 in thymus of wild type and Nr4a1-deficient animals at 8 weeks and 
36 weeks of age (Fig. 7b). Consistent with our finding that Nr4a1-deficient mice have accelerated thymic 
involution at 36 weeks of age, we found elevated expression of both Tnfa and Il6 in Nr4a1−/− thymus 
at 36 weeks of age. Next, we assessed anti-nuclear antibody (ANA) production, a hallmark of a loss of 
self-tolerance and autoimmunity24. We found increased levels of anti-nuclear antibodies in the serum of 
Nr4A1−/− mice, peaking at week 18, indicating that the observed dysregulation of thymic homeostasis 
may contribute to a loss of self-tolerance (Fig. 7c).
Discussion
The transcription factor Nr4a1 has been shown by our group and others to regulate both monocyte 
development and macrophage activation, but its capacity to regulate tissue macrophage development 
has not been investigated19,25,26. In this report, we identify a novel subset of CD11b−F4/80+ tissue mac-
rophages in the thymus that selectively function to clear apoptotic thymocytes. Importantly, we show 
that NR4A1 is critical for the development of this thymic macrophage population, as these cells are 
drastically reduced in mice lacking Nr4a1 expression in myeloid cells. It is likely that the remaining 
thymic CD11b−F4/80+ cells in Nr4A1−/− mice represent an additional tissue macrophage population that 
is independent of NR4A1. Tissue macrophage development in the bone marrow, brain, and spleen in 
Nr4a1−/− mice appeared normal (Fig.  2), indicating that Nr4a1-deficiency does not result in defects in 
global macrophage development. However, we do not rule out that NR4A1 may control the development 
of additional specialized macrophage subsets in tissues not examined in the current study.
NR4A1 functions as the master transcriptional regulator of the non-classical, patrolling subset of 
monocytes. Patrolling monocytes function by surveying the vasculature for both tissue damage and 
infection, however whether these cells are terminally differentiated or whether they extravasate into 
tissue and contribute to macrophage populations is currently unclear27. We hypothesized that any devel-
opmental defect observed within tissue macrophage populations in Nr4a1-deficient mice would likely be 
due to the absence of patrolling monocytes. However, analysis of Cx3cr1-deficient mice, which function 
as an alternative model of patrolling monocyte deficiency, showed no defect in CD11b−F4/80+ thymic 
macrophage subset development (Fig.  5f). Further, analysis of chimerism of CD11b−F4/80+ thymic 
macrophages following parabiosis indicated that circulating short-lived adult monocytes likely do not 
contribute to the thymic macrophage population (Fig. 5g). However, due to the duration of the parabi-
osis experiment (4 weeks), our results rule out short lived-circulating monocytes as potential parent 
cells for NR4A1-dependent thymic macrophages but not longer-lived circulating monocytes or progeni-
tors. Utilizing a Flt3-cre; Rosa26-YFP fate-mapping system, whereby HSC-derived cells are labeled with 
YFP, we found that the thymic CD11b−F4/80+ cells either have at some point, or currently express, Flt3 
(Fig. 5b). Our bone marrow transplant studies also support the notion that these cells are HSC-derived.
At steady state, thousands of cells die by apoptosis and are replaced every second28. These apoptotic 
bodies are rapidly and efficiently cleared primarily by tissue macrophages, however, a number of both 
hematopoietic and non-hematopoietic cells also contribute to their clearance29. In this report we show 
that Nr4a1-deficient mice fail to effectively clear apoptotic thymocytes in vivo following injection with 
dexamethasone (Fig  6c,d). However, only slight differences in Annexin V+7AAD+ cells in the thymus 
were observed between wild type and Nr4a1-knockout mice in the absence of Dex at steady state. This 
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is likely due to the presence of other phagocytic cells within the thymus, particularly eosinophils, den-
dritic cells, and other thymic macrophage subsets that are capable of efferocytosis30,31. Furthermore, 
NR4A1 functions in pro-apoptotic pathways in developing thymocytes, and Nr4a1-deficient mice display 
a reduction in thymocyte apoptosis during T-cell selection32. Thus the increase in thymocyte survival at 
steady state in Nr4a1-deficient mice may mask an apoptotic cell clearance defect resulting from aberrant 
thymic macrophage development32.
Interestingly, maintenance of thymic homeostasis is altered in Nr4a1-deficient mice as these ani-
mals display accelerated thymic demise, with a concomitant increase in pro-inflammatory cytokine pro-
duction (Fig.  7a,b). Further, increased anti-nuclear antibody production is observed in Nr4a1−/− mice 
(Fig. 7c), suggesting that Nr4a1-dependent macrophages may be critical mediators of thymic homeosta-
sis and the control of self-tolerance. While these data are likely the result of impaired thymic macrophage 
development, we cannot formally exclude the possibility that Nr4a1-deficiency in other thymic cells also 
contributes both to the observed accelerated thymic demise and increase in anti-nuclear antibody pro-
duction. We did not, however, observe evidence of pathologic autoimmunity in these animals at one year 
of age (data not shown), suggesting that additional factors compensate for the loss of Nr4a1 to prevent 
autoimmunity.
In sum, we identify a novel subset of NR4A1-dependent CD11b−F4/80+ macrophages in the thymus. 
These cells are proliferative, and function to engulf apoptotic thymocytes and maintain tissue homeosta-
sis. These findings highlight the importance of the transcription factor NR4A1 in myeloid cell develop-
ment, and provide a novel mechanism for tissue and subset specific macrophage development.
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